Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1325 of 1641 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/24/24
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 01/01/24
End: 12/31/27
Due: 12/31/28
Phase: N/A
Priority: Normal
Start: 08/01/23
End: 01/02/26
Due: 01/02/27
Phase: N/A
Priority: Normal
Start: 06/13/22
End: 12/31/27
Due: 12/31/28
Phase: N/A
Priority: Normal
Start: 04/11/13
End: 03/18/24
Due: 03/18/25
Phase: N/A
Priority: Normal
Start: 10/31/05
End: 09/30/08
Due: 09/30/09
Phase: N/A
Priority: Normal
Start: 12/01/10
End: 07/07/15
Due: 07/07/16
Phase: N/A
Priority: Normal
Start: 04/30/13
End: 12/31/16
Due: 12/31/17
Phase: N/A
Priority: Normal
Start: 04/01/19
End: 08/31/23
Due: 08/31/24
Phase: N/A
Priority: Normal
Start: 08/31/15
End: 08/31/16
Due: 08/31/17
Phase: N/A
Priority: Normal
Start: 09/30/24
End: 05/31/26
Due: 05/31/27
Phase: N/A
Priority: Normal
Start: 01/31/11
End: 09/30/15
Due: 09/30/16
Phase: N/A
Priority: Normal
Start: 07/01/24
End: 04/30/26
Due: 04/30/27
Phase: N/A
Priority: Normal
Start: 04/01/27
End: 04/01/29
Due: 04/01/30
Understanding Perceived Access and Receipt of Gender-affirming Treatments Among Transgender Veterans
Phase: N/A
Priority: Normal
Start: 10/23/24
End: 12/31/27
Due: 12/31/28
Phase: N/A
Priority: Normal
Start: 02/01/24
End: 02/01/28
Due: 02/01/29
Phase: N/A
Priority: Normal
Start: 06/01/23
End: 12/31/28
Due: 12/31/29
Phase: N/A
Priority: Normal
Start: 06/30/25
End: 08/31/28
Due: 08/31/29
Phase: N/A
Priority: Normal
Start: 05/19/22
End: 09/30/26
Due: 09/30/27
Phase: N/A
Priority: Normal
Start: 01/31/09
End: 03/31/16
Due: 03/31/17
Phase: N/A
Priority: Normal
Start: 11/30/09
End: 09/30/13
Due: 09/30/14
Phase: N/A
Priority: Normal
Start: 06/15/16
End: 12/29/22
Due: 12/29/23
Phase: N/A
Priority: Normal
Start: 04/30/08
End: 12/31/10
Due: 12/31/11
Phase: N/A
Priority: Normal
Start: 03/01/18
End: 04/20/21
Due: 04/20/22
Phase: N/A
Priority: Normal
Start: 04/02/18
End: 03/31/24
Due: 03/31/25